Physicians' Academy for Cardiovascular Education

Agenda Topics ▼Video ▼Online-CME News ▼Meeting Reports Slides ▼About

ACC 18 ▼BET Inhibition ▼CV Inflammation ▼Diabetes & CVD ▼Expert Meeting GLP-1, CVD & T2DM ▼Invest in your arteries ▼PCSK9 ▼

C-Reactive Protein, Inflammation and Atherosclerosis

Jan. 24, 2016

Continue reading:

5 Things a cardiologist should know about diabetes

Slide Curriculum: Diabetes and cardiology

Slides (curriculum) - July 24, 2018

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy

Hypoglycemia in cardiovascular medicine: why worry?

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria - Online CME

ACC 18

Why cardiologists should be more interested in PAH

3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomberg-Maitland, Falls Church, VA, USA

The future of renal denervation in the treatment of hypertension

3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Michael Böhm, Homburg, Germany

Emerging approaches to dyslipidemia management beyond LDL-c

3' education - Mar. 9, 2018 - VBWG at ACC 2018, Orlando, FL, USA - Eliot Brinton, Salt Lake City, UT, USA

ACS

People with ACS and diabetes particularly benefit from PCSK9 inhibitor and statin treatment

News - June 25, 2018

CV risk remains high up to 5 years after TIA or minor stroke

Literature - May 31, 2018 - Amarenco P, et al. - New Engl J Med 2018

Treatment with statin before PCI intervention reduces MACE in patients with ACS

3' education - Mar. 11, 2018 - ACC 2018, Orlando, FL, VS - Otavio Berwanger - São Paulo, Brasil

Atherosclerosis

Low testosterone/estradiol ratio associated with higher CV risk in men with atherosclerotic disease

Literature - July 30, 2018 - Koeverden ID, et al. - Cardiovasc Res 2018

Advancing insights into Lp(a) as a causal factor in CVD

3' education - June 29, 2018 - John Chapman - Paris, France

Estimating CV risk and treatment benefit

10' education - June 12, 2018 - Prof. Frank Visseren - Utrecht, The Netherlands - Online CME

Atrial fibrillation

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke

Literature - July 26, 2018 - Go AS, et al. - JAMA Cardiol. 2018

Atrial fibrillation & HFpEF: Novel device and therapeutic approaches

10' education - May 27, 2018 - ESC Heart Failure 2018, Vienna - Dipak Kotecha - Birmingham, UK

Nut consumption inversely associated with risk on AF and HF

Literature - July 10, 2018 - Larsson SC, et al. - Heart 2018

BET Inhibition

Cardiovascular disease in diabetes and CKD & residual risk: The promise of epigenetics

10' education - May 25, 2018 - ERA-EDTA - Copenhagen, Denmark - Prof. Erik Stroes - Amsterdam, The Netherlands

Epigenetics in CKD: Rationale for BET inhibition, an emerging therapeutic mechanism in renal disease and CVD

10' education - May 25, 2018 - ERA-EDTA - Copenhagen, Denmark - Louise Nordfors - Stockholm, Sweden

LDL-c: Done Deal, Next Epigenetics?

Agenda - Aug. 25, 2018 - ESC 2018, Munich, Germany

CV Inflammation

Low testosterone/estradiol ratio associated with higher CV risk in men with atherosclerotic disease

Literature - July 30, 2018 - Koeverden ID, et al. - Cardiovasc Res 2018

Mechanisms involved in HFpEF and how they are or may be targeted for therapy

Literature - June 26, 2018 - Lam CSP et al., - Eur Heart J 2018

Yogurt consumption before an unhealthy meal reduces postprandial inflammation

Literature - May 24, 2018 - Pei R, et al. - J Nutr 2018

CVRM

Clinical Updates in the Management of Cardiovascular Risk 2018

Online-CME - Online-CME - This course consists of 4 separate lectures

Comprehensive overview of antidiabetic drug classes: mechanisms, benefits and risks

10' education - Mar. 29, 2018 - Prof Cliff Bailey - Birmingham, UK

How much should Lp(a) be lowered to translate into meaningful CV benefit?

3' education - June 29, 2018 - Brian Ference, MD - Cambridge, UK

Diabetes

Comprehensive overview of antidiabetic drug classes: mechanisms, benefits and risks

10' education - Mar. 29, 2018 - Prof Cliff Bailey - Birmingham, UK

Meeting Impression | Contemporary management of a patient with heart failure and diabetes: Implications from recent trials

May 28, 2018 – Vienna, Austria

Summary | Understanding the mechanisms of SGLT2 inhibition in heart failure and diabetes

Vienna, Austria - May 28, 2018

Diabetes & CVD

Physical activity associated with reduced risk of diabetes at high CVD risk

Literature - Aug. 13, 2018 - Kraus WE et al. - BMJ Open Diab Res Care 2018

Bariatric surgery decreases risk of microvascular complications in obese diabetic patients

Literature - Aug. 9, 2018 - O’Brien R et al. - Ann Intern Med 2018

Comprehensive overview of antidiabetic drug classes: mechanisms, benefits and risks

10' education - Mar. 29, 2018 - Prof Cliff Bailey - Birmingham, UK

Expert Meeting GLP-1, CVD & T2DM

Translation of novel approaches in CVD & diabetes to clinical practice

10' education - Mar. 22, 2018 - John Deanfield, Francesco Cosentino, Filip Knop

Novel diabetes drugs in clinical management: Extending the opportunities

10' education - June 5, 2018 - Stefano Taddei, Cees Tack, Massimo Volpe

Clinical trials in diabetes and CVD: What did we learn?

10' education - Mar. 22, 2018 - Filippo Crea, Angelyn Bethel, Eduard Montanya

Familial Hypercholesterolemia

Clinical genetic testing provides improved diagnosis of FH

News - Aug. 13, 2018

Oral microsomal triglyceride transfer protein inhibitor is beneficial in HoFH

Literature - June 28, 2018 - Blom DJ, et al. - Orphanet J Rare Dis 2018

PCSK9 inhibition: Science, Outcomes & Guidance

Agenda - Aug. 25, 2018 - ESC 2018, Munich, Germany

GLP-1 RA & CVD

Comprehensive overview of antidiabetic drug classes: mechanisms, benefits and risks

10' education - Mar. 29, 2018 - Prof Cliff Bailey - Birmingham, UK

Meeting Impression | Contemporary management of a patient with heart failure and diabetes: Implications from recent trials

May 28, 2018 – Vienna, Austria

Summary | Guidance from outcome trials: What are the clinical implications

Vienna, Austria - May 28, 2018

Heart Failure

ARNI provided no additional benefit on renal function compared with ARB

Literature - Aug. 7, 2018 - Haynes R et al. - Circulation 2018; published online ahead of print

Meeting Impression | Contemporary management of a patient with heart failure and diabetes: Implications from recent trials

May 28, 2018 – Vienna, Austria

Summary | Understanding the mechanisms of SGLT2 inhibition in heart failure and diabetes

Vienna, Austria - May 28, 2018

Hypertension

Clinical Updates in the Management of Cardiovascular Risk 2018

Online-CME - Online-CME - This course consists of 4 separate lectures

Summary | Diabetes: How to reduce risk from a cardiovascular perspective?

May 3, 2018 – Prof. Diederick Grobbee, MD

Even normotensive young blacks have a higher risk of hypertension than whites

Literature - July 19, 2018 - Thomas SJ, et al. - J Am Heart Assoc. 2018

Inflammation Expert Opinions

Ultime notizie sulla terapia: Un farmaco anti-infiammatorio riduce eventi cardiovascolari maggiori

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Breakthrough therapy: Anti-inflammatory drug can affect important CV outcomes

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Clinical implications of inhibiting inflammation as risk factor for progression of CVD

5' education - Aug. 27, 2017

Invest in your arteries

Estimating CV risk and treatment benefit

10' education - June 12, 2018 - Prof. Frank Visseren - Utrecht, The Netherlands - Online CME

Importance of hypertension in CVD prevention

10' education - June 12, 2018 - Prof. Richard Hobbs - Oxford, UK - Online CME

The role of lipids in CVD prevention: Lessons learned about statins

10' education - June 6, 2018 - Prof. Kees Hovingh - Amsterdam, The Netherlands - Online CME

Lipids

Clinical Updates in the Management of Cardiovascular Risk 2018

Online-CME - Online-CME - This course consists of 4 separate lectures

Time to benefit varies substantially between cholesterol-lowering agents

Literature - Aug. 1, 2018 - Barter PJ & Waters DD - J Clin Lipidol. 2018

Advancing insights into Lp(a) as a causal factor in CVD

3' education - June 29, 2018 - John Chapman - Paris, France

Lp(a)

How much should Lp(a) be lowered to translate into meaningful CV benefit?

3' education - June 29, 2018 - Brian Ference, MD - Cambridge, UK

Advancing insights into Lp(a) as a causal factor in CVD

3' education - June 29, 2018 - John Chapman - Paris, France

CVD risk associated with high Lp(a) reduced at low LDL-c in primary prevention setting

Literature - July 5, 2018 - Verbeek R, et al. - Eur Heart J 2018

PAH - Q&A

Pulmonary Arterial Hypertension: Key answers adressed

Online-CME - This course consists of 3 separate lectures

What is the underlying pathophysiology of PAH and what are its characteristics?

3' education - Jan. 11, 2017 - Bologna, Italy - Nazzareno Galiè, MD

Which clinical PH groups can be distinguished?

3' education - Jan. 10, 2017 - Bologna, Italy - Prof Nazzareno Galiè

PCSK9

Clinical genetic testing provides improved diagnosis of FH

News - Aug. 13, 2018

A large reduction in Lp(a) is necessary to achieve a meaningful reduction of CHD risk

Literature - July 3, 2018 - Burgess S, et al. - JAMA Cardiol 2018

Greater absolute benefit with PCSK9 inhibition in diabetes patients

3' education - July 3, 2018 - Prof. Kausik Ray, Imperial College London, UK

PCSK9 expert opinions

PCSK9 inhibition works, but you can’t force biology

10' education - Mar. 17, 2017 - Prof. Wouter Jukema – Leiden University Medical Center, The Netherlands - ACC 2017, Washington DC, USA

Identification of patients who will benefit is important after FOURIER

10' education - Mar. 19, 2017 - Prof. Ulf Landmesser - Charité - Universitätsmedizin Berlin, Germany - ACC 2017, Washington DC, USA

Landmark study with PCSK9 inhibitor will change clinical practice

10' education - Mar. 18, 2017 - Prof. Eric Bruckert - Pitié-Salpêtrière Hospital, Paris, France - ACC 2017, Washington DC, USA

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension: Key answers adressed

Online-CME - This course consists of 3 separate lectures

Why cardiologists should be more interested in PAH

3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomberg-Maitland, Falls Church, VA, USA

Novel insights in the management and prognosis of pulmonary hypertension

5' education - Aug. 29, 2017 - ESC 2017, Barcelona, Spain - Prof Nazzareno Galiè - Bologna, Italy

Stroke

Reduced risk of ischemic events but higher risk of hemorrhages with DAPT after ischemic stroke or TIA

Literature - July 25, 2018 - Johnston C, et al. - N Engl J Med 2018

LDL-triglycerides associated with increased CVD risk

Literature - July 18, 2018 - Saeed A, et al. - JACC 2018

Reduced CV risk with intensive blood pressure treatment in T2DM patients on standard glycemic control

Literature - July 11, 2018 - Tsujimoto T and Kajio H. - Hypertension. 2018

© 2006 - 2018 pace-cme.org - About